Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Other
  • (-) ≠ Faculty of Science
  • (-) = Locatelli, F.

Search results

  • RSS Feed
(1 - 11 of 11)
The EHA research roadmap: immune-based therapies for hematological malignancies
Einsele, H.; Briones, J.; Ciceri, F.; Cadenas, I.G.; Falkenburg, F.; Bolanos, N.; ... ; Loosdrecht, A.A. van de 2021
The EHA research roadmap: immune-based therapies for hematological malignancies
Other
open access
Immune-based therapies for hematological malignancies: an update by the EHA SWG on immunotherapy of hematological malignancies
Einsele, H.; Briones, J.; Ciceri, F.; Garcia-Cadenas, I.; Falkenburg, F.; Bolanos, N.; ... ; Loosdrecht, A.A. van de 2020
Immune-based therapies for hematological malignancies: an update by the EHA SWG on immunotherapy of hematological malignancies
Other
open access
Results of allogeneic stem cell transplantation in patients affected by Shwachman-Diamond syndrome. A retrospective study of SAA-EBMT
Cesaro, S.; Tridello, G.; Kratz, C.; Pillon, M.; Halkes, S.; Lanino, E.; ... ; Dufour, C. 2018
Results of allogeneic stem cell transplantation in patients affected by Shwachman-Diamond syndrome. A retrospective study of SAA-EBMT
Other
metadata only
Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children
Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Giorgiani, G.; Roelofs, H.; Cometa, A.M.; ... ; Locatelli, F. 2011
Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children
Other
metadata only
MESENCHYMAL STROMAL CELL TREATMENT IN CHILDREN WITH ACUTE GVHD. TIME FOR A RANDOMIZED STUDY OF EARLY INTERVENTION?
Ball, L.; Bernardo, M.E.; Lankester, A.; Tol, M. van; Locatelli, F.; Egeler, M. 2010
MESENCHYMAL STROMAL CELL TREATMENT IN CHILDREN WITH ACUTE GVHD. TIME FOR A RANDOMIZED STUDY OF EARLY INTERVENTION?
Other
metadata only
Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome
Ball, L.M.; Bernardo, M.E.; Zwaginga, J.J.; Tol, M. van; Cometa, A.; Roelofs, H.; ... ; Lankester, A. 2010
Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome
Other
metadata only
Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome
Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Avanzini, M.A.; Lankester, A.C.; Roelofs, H.; ... ; Locatelli, F. 2010
Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome
Other
metadata only
Multiple infusions of haploidentical mesenchymal stromal cells are not immunogenic in children undergoing myeloablative stem cell transplantation
Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Roelofs, H.; Zwaginga, J.J.; Locatelli, F.; ... ; Egeler, R.M. 2010
Multiple infusions of haploidentical mesenchymal stromal cells are not immunogenic in children undergoing myeloablative stem cell transplantation
Other
metadata only
Long-term follow-up and risk factors for outcomes after related HLA-identical cord blood transplantation for patients with malignancies. An analysis on behalf of Eurocord-EBMT
Herr, A.L.; Kabbara, N.; Teira, P.; Bonfirm, C.; Locatelli, F.; Tiedemann, K.; ... ; Rocha, V. 2010
Long-term follow-up and risk factors for outcomes after related HLA-identical cord blood transplantation for patients with malignancies. An analysis on behalf of Eurocord-EBMT
Other
metadata only
Gastrointestinal steroid refractory GvHD in children successfully treated with mesenchymal stromal cells cannot be solely assessed by clinical response
Ball, L.M.; Schweizer, J.; Lankester, A.; Bernardo, M.E.; Tol, M.J.D. van; Roelofs, H.; ... ; Egeler, R.M. 2010
Gastrointestinal steroid refractory GvHD in children successfully treated with mesenchymal stromal cells cannot be solely assessed by clinical response
Other
metadata only
Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome
Ball, L.M.; Bernardo, M.E.; Tol, M.J.D. van; Avanzini, M.A.; Lankester, A.C.; Roelofs, H.; ... ; Locatelli, F. 2010
Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome
Other
metadata only